LATIN AMERICA COUGH SYRUP MARKET 2023-2030

Lifesciences | Pharmaceuticals

LATIN AMERICA COUGH SYRUP MARKET 2023-2030

Market by Product Type, Age Group, Distribution Channel, and Country Outlook | Forecast 2023-2030

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton Market Research’s report, the cough syrup market in Latin America is projected to register growth at a CAGR of 3.18% during the forecasted period from 2023 to 2030.


Report scope can be customized per your requirements - Request Free Sample Report 

The countries assessed in the region are:

•         Brazil

•         Mexico

•         Rest of Latin America

In Latin America, the cough syrup market is fueled by multiple factors, including rising concern for respiratory well-being. Concurrently, the region’s rising middle class and growing health consciousness contribute to a growing preference for over-the-counter remedies. However, expansion in this market encounters obstacles arising from regulatory challenges, disparities in healthcare infrastructure, and the proliferation of counterfeit medications.

Brazil captures the highest share of the region’s market. The nation stands to host Latin America’s largest pharmaceutical sector. The transition in Brazil’s administration during 2022 brought about notable changes in the pharmaceutical landscape. Specifically, it reduced the audit requirements for certain pharmaceutical products and simplified the process of introducing new products. With fewer regulatory hurdles and a smoother product launch process, global players became more inclined to tap into the Brazilian pharmaceutical market. As a result, this transformation has augmented the cough syrup market’s expansion.

Cough suppressants, also known as antitussives, are medications that mitigate or eliminate coughing by targeting the brain’s cough reflex to reduce the urge to cough. Their demand has risen due to various factors, including ongoing global health challenges such as COVID-19. Coughing is a common symptom of respiratory infections, which has heightened public awareness regarding coughing and its potential for transmitting diseases. Consequently, individuals experiencing mild coughs due to allergies, colds, or other causes may be more inclined to seek cough suppressants to manage their symptoms and reduce the perceived risk of spreading illness.

The market’s growth is determined based on product type, age group, and distribution channel. Based on product type, it is sectioned into cough suppressants, combination medicines, and expectorants.

Some of the known companies in the market are GSK Plc, Reckitt Benckiser Group Plc, Pfizer Inc, Novartis AG, The Procter & Gamble Company, and Sanofi SA.

GSK Plc, a multinational conglomerate in the pharmaceutical and healthcare sector, has solidified its position as a leader through scientific innovation, research, and collaborative efforts. Offering a comprehensive range of medications, vaccines, and consumer healthcare products, GSK addresses a diverse spectrum of health concerns across its three primary business segments: pharmaceuticals, vaccines, and consumer healthcare. With a global footprint encompassing Latin America and other regions, GSK’s headquarters is situated in Brentford, UK.


Key deliverables of the report:

·       Market CAGR during the forecasting years 2023-2030

·       Detailed data highlighting key insights, industry components, and market strategies

·       Comprehensive information and estimation of the cough syrup market revenue growth in Latin America and its influence on the parent market

·       In-depth study of forthcoming trends in consumer behavioral patterns

·       A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces

·       A wide-ranging study of factors that will challenge the LA cough syrup market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. LATIN AMERICA COUGH SYRUP MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT ANALYSIS ON THE COUGH SYRUP MARKET

2.1.1. COVID-19 IMPACT

2.1.2. UKRAINE-RUSSIA WAR IMPACT

2.2. PORTER’S FIVE FORCES ANALYSIS

2.2.1. THREAT OF NEW ENTRANTS

2.2.2. THREAT OF SUBSTITUTES

2.2.3. BARGAINING POWER OF BUYERS

2.2.4. BARGAINING POWER OF SUPPLIERS

2.2.5. THREAT OF COMPETITIVE RIVALRY

2.3. INDUSTRY COMPONENTS

2.3.1. RAW MATERIALS

2.3.2. MANUFACTURERS

2.3.3. DISTRIBUTORS

2.3.4. RETAILERS

2.4. REGULATORY FRAMEWORK

2.5. KEY MARKET STRATEGIES

2.5.1. COLLABORATIONS

2.5.2. PRODUCT LAUNCHES

2.5.3. ACQUISITIONS

2.5.4. BUSINESS DIVESTITURES & EXPANSIONS

2.6. MARKET DRIVERS

2.6.1. HIGH INCIDENCE OF RESPIRATORY AILMENTS

2.6.2. VULNERABILITY TO RESPIRATORY DISEASES AMONG THE GERIATRIC POPULATION

2.6.3. INNOVATIONS IN COUGH SYRUPS

2.7. MARKET CHALLENGES

2.7.1. OVERDOSE RISKS ASSOCIATED WITH COUGH SYRUPS

2.7.2. STRICT REGULATORY REQUIREMENTS

2.7.3. INCREASING COUGH SYRUP DEATHS DUE TO TOXIC INGREDIENTS

2.8. MARKET OPPORTUNITIES

2.8.1. SELF-MEDICATION TRENDS INCREASE DEMAND FOR OTC DRUGS

2.8.2. HERBAL COUGH SYRUPS EMERGE AS A SAFER ALTERNATIVE

2.8.3. EASE OF PURCHASE OFFERED BY E-COMMERCE CHANNELS

2.8.4. AVAILABILITY OF SUGAR-FREE COUGH SYRUPS

2.8.5. GROWING PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS

2.9. ANALYST PERSPECTIVE

3. LATIN AMERICA COUGH SYRUP MARKET – BY PRODUCT TYPE

3.1. COUGH SUPPRESSANTS

3.2. COMBINATION MEDICINES

3.3. EXPECTORANTS

4. LATIN AMERICA COUGH SYRUP MARKET – BY AGE GROUP

4.1. ADULTS

4.2. ADOLESCENTS

4.3. PEDIATRIC

5. LATIN AMERICA COUGH SYRUP MARKET – BY DISTRIBUTION CHANNEL

5.1. RETAIL PHARMACIES

5.2. HOSPITAL PHARMACIES

5.3. E-PHARMACIES

6. LATIN AMERICA COUGH SYRUP MARKET – BY COUNTRY OUTLOOK

6.1. BRAZIL

6.1.1. BRAZIL COUGH SYRUP MARKET FORECAST & PROSPECTS

6.2. MEXICO

6.2.1. MEXICO COUGH SYRUP MARKET FORECAST & PROSPECTS

6.3. REST OF LATIN AMERICA

6.3.1. REST OF LATIN AMERICA COUGH SYRUP MARKET FORECAST & PROSPECTS

7. COMPETITIVE LANDSCAPE

7.1. GSK PLC

7.1.1. OVERVIEW

7.1.2. PRODUCT PORTFOLIO

7.1.3. KEY STRENGTHS

7.1.4. KEY CHALLENGES

7.2. PFIZER INC

7.2.1. OVERVIEW

7.2.2. PRODUCT PORTFOLIO

7.2.3. KEY STRENGTHS

7.2.4. KEY CHALLENGES

7.3. NOVARTIS AG

7.3.1. OVERVIEW

7.3.2. PRODUCT PORTFOLIO

7.3.3. KEY STRENGTHS

7.3.4. KEY CHALLENGES

7.4. RECKITT BENCKISER GROUP PLC

7.4.1. OVERVIEW

7.4.2. PRODUCT PORTFOLIO

7.4.3. KEY STRENGTHS

7.4.4. KEY CHALLENGES

7.5. THE PROCTER & GAMBLE COMPANY

7.5.1. OVERVIEW

7.5.2. PRODUCT PORTFOLIO

7.5.3. KEY STRENGTHS

7.5.4. KEY CHALLENGES

7.6. SANOFI SA

7.6.1. OVERVIEW

7.6.2. PRODUCT PORTFOLIO

7.6.3. KEY STRENGTHS

7.6.4. KEY CHALLENGES

7.7. CIPLA LIMITED

7.7.1. OVERVIEW

7.7.2. PRODUCT PORTFOLIO

7.7.3. KEY STRENGTHS

7.7.4. KEY CHALLENGES

7.8. KENVUE INC

7.8.1. OVERVIEW

7.8.2. PRODUCT PORTFOLIO

7.8.3. KEY STRENGTHS

7.8.4. KEY CHALLENGES

7.9. ASTRAZENECA PLC

7.9.1. OVERVIEW

7.9.2. PRODUCT PORTFOLIO

7.9.3. KEY STRENGTHS

7.9.4. KEY CHALLENGES

7.10. ACELLA PHARMACEUTICALS LLC

7.10.1. OVERVIEW

7.10.2. PRODUCT PORTFOLIO

7.10.3. KEY STRENGTHS

7.10.4. KEY CHALLENGES

7.11. THE HIMALAYA WELLNESS COMPANY

7.11.1. OVERVIEW

7.11.2. PRODUCT PORTFOLIO

7.11.3. KEY STRENGTHS

7.11.4. KEY CHALLENGES

7.12. MERCK KGAA

7.12.1. OVERVIEW

7.12.2. PRODUCT PORTFOLIO

7.12.3. KEY STRENGTHS

7.12.4. KEY CHALLENGES

7.13. ABBOTT LABORATORIES

7.13.1. OVERVIEW

7.13.2. PRODUCT PORTFOLIO

7.13.3. KEY STRENGTHS

7.13.4. KEY CHALLENGES

7.14. GLENMARK PHARMACEUTICALS LIMITED

7.14.1. OVERVIEW

7.14.2. PRODUCT PORTFOLIO

7.14.3. KEY STRENGTHS

7.14.4. KEY CHALLENGES

7.15. DABUR INDIA LTD

7.15.1. OVERVIEW

7.15.2. PRODUCT PORTFOLIO

7.15.3. KEY STRENGTHS

7.15.4. KEY CHALLENGES

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: LATIN AMERICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 2: REGULATORY FRAMEWORK

TABLE 3: LIST OF COLLABORATIONS

TABLE 4: LIST OF PRODUCT LAUNCHES

TABLE 5: LIST OF ACQUISITIONS

TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS

TABLE 7: LATIN AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)

TABLE 8: LATIN AMERICA COUGH SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)

TABLE 9: LATIN AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)

TABLE 10: LATIN AMERICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

List of Figures

FIGURE 1: INDUSTRY COMPONENTS

FIGURE 2: LATIN AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN %)

FIGURE 3: LATIN AMERICA COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2030 (IN $ MILLION)

FIGURE 4: LATIN AMERICA COUGH SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2030 (IN $ MILLION)

FIGURE 5: LATIN AMERICA COUGH SYRUP MARKET, BY AGE GROUP, 2022 & 2030 (IN %)

FIGURE 6: LATIN AMERICA COUGH SYRUP MARKET, BY ADULTS, 2023-2030 (IN $ MILLION)

FIGURE 7: LATIN AMERICA COUGH SYRUP MARKET, BY ADOLESCENTS, 2023-2030 (IN $ MILLION)

FIGURE 8: LATIN AMERICA COUGH SYRUP MARKET, BY PEDIATRIC, 2023-2030 (IN $ MILLION)

FIGURE 9: LATIN AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2030 (IN %)

FIGURE 10: LATIN AMERICA COUGH SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 11: LATIN AMERICA COUGH SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 12: LATIN AMERICA COUGH SYRUP MARKET, BY E-PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 13: LATIN AMERICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)

FIGURE 14: BRAZIL COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 15: MEXICO COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 16: REST OF LATIN AMERICA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying